Fisher unit pursues RNA research

October 21, 2005

NH Business Review Staff,

A business unit of Fisher Scientific is teaming up with Alcon Incorporated to use RNA research to develop drugs that can be delivered through the eye.

Dharmacon, the Colorado based business unit of Fisher Biosciences, itself a unit of the Hampton-based corporation, specializes in making products that interfere with RNA, thus silencing disease-causing genes. This RNA interference (RNAi) enables it to target organisms that previously were not treatable by drugs.

Alcon, a German company with headquarters in Dallas, Texas, is known for its eye care products.

Financial terms of the multi-year deal were not disclosed. — NHBR STAFF REPORT

Categories: News

More news from NHBR:

'From the Battlefield to the Boardroom' with Robert Campbell

Author, leadership coach and veteran of 27 years in the Army, Robert Campbell speaks on his 'Battlefield to Boardroom' book series and how companies can become veteran-ready

Live-work-create tech village eyed for Manchester

A tech-entrepreneur turned venture capitalist is eyeing one of the largest undeveloped tracts in Manchester for a community where tech- and startup-minded people would live and work. Freedom Village would be located on 250 acres of mostly wooded land at Hackett Hill, which is located in the northwestern corner of Manchester.

NHBR About Town: Week of October 9, 2026

Business and event happenings around the state of NH

Manchester property values jump nearly 50%

The value of all property in Manchester increased by almost half — 48% ‑ over the past five years, according to preliminary data released by city officials on Oct. 13 The valuations, compiled due to a citywide revaluation, add up to $23.09 billion. The current value of city properties is $15.56 billion, which was based on assessments made during the city's last revaluation.